GHRP-2
Growth Hormone Releasing Peptide-2
GHRP-2 (Growth Hormone Releasing Peptide-2), also known as pralmorelin, is a synthetic hexapeptide that acts as a potent agonist at the ghrelin/growth hormone secretagogue receptor (GHS-R). It triggers pulsatile growth hormone release from the pituitary gland, mimicking the body's natural GH secretion patterns. GHRP-2 was developed as a diagnostic agent and is clinically approved in Japan for assessing growth hormone deficiency. Unlike direct GH administration, GHRP-2 works through the body's natural pathways, making it a preferred option for those seeking to enhance their natural growth hormone production safely and effectively.
Complete Dosing Guide
Special Considerations
Desensitization:
- GH response may decrease with repeated dosing
- Implement cycling protocols (8-12 weeks on, 4 weeks off)
- Space doses at least 3 hours apart
Food Interactions:
- High blood glucose blunts GH response
- Avoid carbohydrates 30-60 minutes pre/post injection
- Fats and proteins have minimal impact
Age Factors:
- Older adults may require lower doses
- Start at 50-100 mcg per dose if over 50 years old
- Monitor for side effects more closely
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.